Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell. | Front Endocrinol (Lausanne) | 2022 | 36147573 | PubTator, text mining | PubMed |
| Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors. | Pharmaceuticals (Basel) | 2022 | 36145375 | PubTator, text mining | PubMed |
| The Physiological Function and Potential Role of the Ubiquitous Na+/H+ Exchanger Isoform 8 (NHE8): An Overview Data. | Int J Mol Sci | 2022 | 36142772 | PubTator, text mining | PubMed |
| Impact of SSTR PET on Inter-Observer Variability of Target Delineation of Meningioma and the Possibility of Using Threshold-Based Segmentations in Radiation Oncology. | Cancers (Basel) | 2022 | 36139596 | PubTator, text mining | PubMed |
| Cerebral Organoids as an Experimental Platform for Human Neurogenomics. | Cells | 2022 | 36139380 | PubTator, text mining | PubMed |
| Identification of Unique Genetic Biomarkers of Various Subtypes of Glomerulonephritis Using Machine Learning and Deep Learning. | Biomolecules | 2022 | 36139115 | PubTator, text mining | PubMed |
| Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review. | Front Endocrinol (Lausanne) | 2022 | 36133304 | PubTator, text mining | PubMed |
| Recurrent paraganglioma of the vulva: A rare case report and review of the literature. | Front Oncol | 2022 | 36091178 | PubTator, text mining | PubMed |
| Favorable Effects of Octreotide in Congenital Chloride Diarrhea Associated With CKD. | Kidney Int Rep | 2022 | 36090494 | PubTator, text mining | PubMed |
| Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics. | Front Mol Biosci | 2022 | 36090051 | PubTator, text mining | PubMed |
| RNA sequencing reveals lncRNA-mediated non-mendelian inheritance of feather growth change in chickens. | Genes Genomics | 2022 | 36087248 | PubTator, text mining | PubMed |
| Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art. | Cancers (Basel) | 2022 | 36077631 | PubTator, text mining | PubMed |
| Advanced imaging and theranostics in thyroid cancer. | Curr Opin Endocrinol Diabetes Obes | 2022 | 36068937 | PubTator, text mining | PubMed |
| [Clinicopathological Features of Meningiomas in Tibet]. | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | 2022 | 36065695 | PubTator, text mining | PubMed |
| Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET. | EJNMMI Radiopharm Chem | 2022 | 36064987 | PubTator, text mining | PubMed |
| Comparison of the Sensitivity of 68 Ga-DOTATATE PET/CT with Other Imaging Modalities in Detecting Head and Neck Paraganglioma: Experience from Western India. | World J Nucl Med | 2022 | 36060084 | PubTator, text mining | PubMed |
| Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature. | Cancer Imaging | 2022 | 36057635 | PubTator, text mining | PubMed |
| Pituicytoma: A rare case report of sellar and suprasellar tumor. | Int J Surg Case Rep | 2022 | 36057248 | PubTator, text mining | PubMed |
| A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36051390 | PubTator, text mining | PubMed |
| Fate decisions of breast cancer stem cells in cancer progression. | Front Oncol | 2022 | 36046046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=45